Rigel Pharma earns M payment from AstraZeneca - BusinessWeek

Rigel Pharma earns M payment from AstraZeneca BusinessWeek AstraZeneca said last week that fostamatinib met its goal in a mid-stage trial, as it worked better than a placebo at treating rheumatoid arthritis symptoms ... and more »

Roche seeks to broaden arthritis drug use in EU, US - Reuters

Roche seeks to broaden arthritis drug use in EU, US Reuters The drug is mainly targeted at rheumatoid arthritis, but a late-stage study published in June showed it improved the signs and symptoms of sJIA. ... Roche seeks approval for arthritis drugIrish Times all 9 news articles »

Don't smoke out all your joints yet - Daily News & Analysis

Don't smoke out all your joints yet Daily News & Analysis The World Health Organisation (WHO) estimates that one in six people and one in three families are affected by arthritis. Rheumatoid arthritis and ... and more »

Looking Into Pharmas - Seeking Alpha

Looking Into Pharmas Seeking Alpha This segment's products also comprise Celebrex for osteoarthritis and rheumatoid arthritis and acute pain; Zyvox for Gram-positive pathogens; ... and more »